Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 357

1.

Fibronectin rescues estrogen receptor α from lysosomal degradation in breast cancer cells.

Sampayo RG, Toscani AM, Rubashkin MG, Thi K, Masullo LA, Violi IL, Lakins JN, Cáceres A, Hines WC, Coluccio Leskow F, Stefani FD, Chialvo DR, Bissell MJ, Weaver VM, Simian M.

J Cell Biol. 2018 Jul 6. pii: jcb.201703037. doi: 10.1083/jcb.201703037. [Epub ahead of print]

PMID:
29980625
2.

hMENA isoforms impact NSCLC patient outcome through fibronectin/β1 integrin axis.

Di Modugno F, Spada S, Palermo B, Visca P, Iapicca P, Di Carlo A, Antoniani B, Sperduti I, Di Benedetto A, Terrenato I, Mottolese M, Gandolfi F, Facciolo F, Chen EI, Schwartz MA, Santoni A, Bissell MJ, Nisticò P.

Oncogene. 2018 Jun 15. doi: 10.1038/s41388-018-0364-3. [Epub ahead of print]

PMID:
29907768
3.
4.

Transient external force induces phenotypic reversion of malignant epithelial structures via nitric oxide signaling.

Ricca BL, Venugopalan G, Furuta S, Tanner K, Orellana WA, Reber CD, Brownfield DG, Bissell MJ, Fletcher DA.

Elife. 2018 Mar 21;7. pii: e26161. doi: 10.7554/eLife.26161.

5.

Laminin-111 and the Level of Nuclear Actin Regulate Epithelial Quiescence via Exportin-6.

Fiore APZP, Spencer VA, Mori H, Carvalho HF, Bissell MJ, Bruni-Cardoso A.

Cell Rep. 2017 Jun 6;19(10):2102-2115. doi: 10.1016/j.celrep.2017.05.050.

6.

Pathways Involved in Formation of Mammary Organoid Architecture Have Keys to Understanding Drug Resistance and to Discovery of Druggable Targets.

Furuta S, Bissell MJ.

Cold Spring Harb Symp Quant Biol. 2016;81:207-217. doi: 10.1101/sqb.2016.81.030825. Epub 2017 Apr 17. Review.

PMID:
28416576
7.

Pre-metastatic niches: organ-specific homes for metastases.

Peinado H, Zhang H, Matei IR, Costa-Silva B, Hoshino A, Rodrigues G, Psaila B, Kaplan RN, Bromberg JF, Kang Y, Bissell MJ, Cox TR, Giaccia AJ, Erler JT, Hiratsuka S, Ghajar CM, Lyden D.

Nat Rev Cancer. 2017 May;17(5):302-317. doi: 10.1038/nrc.2017.6. Epub 2017 Mar 17. Review.

PMID:
28303905
8.

Receptor for hyaluronan mediated motility (RHAMM/HMMR) is a novel target for promoting subcutaneous adipogenesis.

Bahrami SB, Tolg C, Peart T, Symonette C, Veiseh M, Umoh JU, Holdsworth DW, McCarthy JB, Luyt LG, Bissell MJ, Yazdani A, Turley EA.

Integr Biol (Camb). 2017 Mar 1;9(3):223-237. doi: 10.1039/c7ib00002b. Epub 2017 Feb 20.

9.

The pattern of hMENA isoforms is regulated by TGF-β1 in pancreatic cancer and may predict patient outcome.

Melchionna R, Iapicca P, Di Modugno F, Trono P, Sperduti I, Fassan M, Cataldo I, Rusev BC, Lawlor RT, Diodoro MG, Milella M, Grazi GL, Bissell MJ, Scarpa A, Nisticò P.

Oncoimmunology. 2016 Aug 12;5(12):e1221556. doi: 10.1080/2162402X.2016.1221556. eCollection 2016.

10.

FAM83 family oncogenes are broadly involved in human cancers: an integrative multi-omics approach.

Snijders AM, Lee SY, Hang B, Hao W, Bissell MJ, Mao JH.

Mol Oncol. 2017 Feb;11(2):167-179. doi: 10.1002/1878-0261.12016. Epub 2017 Jan 9.

11.

Goodbye flat biology - time for the 3rd and the 4th dimensions.

Bissell MJ.

J Cell Sci. 2017 Jan 1;130(1):3-5. doi: 10.1242/jcs.200550. Review. No abstract available.

12.

Organoids: A historical perspective of thinking in three dimensions.

Simian M, Bissell MJ.

J Cell Biol. 2017 Jan 2;216(1):31-40. doi: 10.1083/jcb.201610056. Epub 2016 Dec 28. Review.

13.

Metastasis: Pathways of parallel progression.

Ghajar CM, Bissell MJ.

Nature. 2016 Dec 14. doi: 10.1038/nature21104. [Epub ahead of print] No abstract available.

PMID:
27974802
15.

Deep nuclear invaginations are linked to cytoskeletal filaments - integrated bioimaging of epithelial cells in 3D culture.

Jorgens DM, Inman JL, Wojcik M, Robertson C, Palsdottir H, Tsai WT, Huang H, Bruni-Cardoso A, López CS, Bissell MJ, Xu K, Auer M.

J Cell Sci. 2017 Jan 1;130(1):177-189. doi: 10.1242/jcs.190967. Epub 2016 Aug 5.

16.

Nuclear repartitioning of galectin-1 by an extracellular glycan switch regulates mammary morphogenesis.

Bhat R, Belardi B, Mori H, Kuo P, Tam A, Hines WC, Le QT, Bertozzi CR, Bissell MJ.

Proc Natl Acad Sci U S A. 2016 Aug 16;113(33):E4820-7. doi: 10.1073/pnas.1609135113. Epub 2016 Aug 5.

17.

New insight into the role of MMP14 in metabolic balance.

Mori H, Bhat R, Bruni-Cardoso A, Chen EI, Jorgens DM, Coutinho K, Louie K, Bowen BB, Inman JL, Tecca V, Lee SJ, Becker-Weimann S, Northen T, Seiki M, Borowsky AD, Auer M, Bissell MJ.

PeerJ. 2016 Jul 13;4:e2142. doi: 10.7717/peerj.2142. eCollection 2016.

18.

Inhibitors of Rho kinase (ROCK) signaling revert the malignant phenotype of breast cancer cells in 3D context.

Matsubara M, Bissell MJ.

Oncotarget. 2016 May 31;7(22):31602-22. doi: 10.18632/oncotarget.9395.

19.

184AA3: a xenograft model of ER+ breast adenocarcinoma.

Hines WC, Kuhn I, Thi K, Chu B, Stanford-Moore G, Sampayo R, Garbe JC, Stampfer M, Borowsky AD, Bissell MJ.

Breast Cancer Res Treat. 2016 Jan;155(1):37-52. doi: 10.1007/s10549-015-3649-z. Epub 2015 Dec 12.

20.

Uncovering the dual role of RHAMM as an HA receptor and a regulator of CD44 expression in RHAMM-expressing mesenchymal progenitor cells.

Veiseh M, Leith SJ, Tolg C, Elhayek SS, Bahrami SB, Collis L, Hamilton S, McCarthy JB, Bissell MJ, Turley E.

Front Cell Dev Biol. 2015 Oct 15;3:63. doi: 10.3389/fcell.2015.00063. eCollection 2015.

21.

Tumour exosome integrins determine organotropic metastasis.

Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, Tesic Mark M, Molina H, Kohsaka S, Di Giannatale A, Ceder S, Singh S, Williams C, Soplop N, Uryu K, Pharmer L, King T, Bojmar L, Davies AE, Ararso Y, Zhang T, Zhang H, Hernandez J, Weiss JM, Dumont-Cole VD, Kramer K, Wexler LH, Narendran A, Schwartz GK, Healey JH, Sandstrom P, Labori KJ, Kure EH, Grandgenett PM, Hollingsworth MA, de Sousa M, Kaur S, Jain M, Mallya K, Batra SK, Jarnagin WR, Brady MS, Fodstad O, Muller V, Pantel K, Minn AJ, Bissell MJ, Garcia BA, Kang Y, Rajasekhar VK, Ghajar CM, Matei I, Peinado H, Bromberg J, Lyden D.

Nature. 2015 Nov 19;527(7578):329-35. doi: 10.1038/nature15756. Epub 2015 Oct 28.

22.

Reversible Aptamer-Au Plasmon Rulers for Secreted Single Molecules.

Lee SE, Chen Q, Bhat R, Petkiewicz S, Smith JM, Ferry VE, Correia AL, Alivisatos AP, Bissell MJ.

Nano Lett. 2015 Jul 8;15(7):4564-70. doi: 10.1021/acs.nanolett.5b01161. Epub 2015 Jun 18.

23.

Modelling breast cancer requires identification and correction of a critical cell lineage-dependent transduction bias.

Hines WC, Yaswen P, Bissell MJ.

Nat Commun. 2015 Apr 21;6:6927. doi: 10.1038/ncomms7927.

24.

Mammary gland development: cell fate specification, stem cells and the microenvironment.

Inman JL, Robertson C, Mott JD, Bissell MJ.

Development. 2015 Mar 15;142(6):1028-42. doi: 10.1242/dev.087643. Review.

25.

Identification of genetic loci that control mammary tumor susceptibility through the host microenvironment.

Zhang P, Lo A, Huang Y, Huang G, Liang G, Mott J, Karpen GH, Blakely EA, Bissell MJ, Barcellos-Hoff MH, Snijders AM, Mao JH.

Sci Rep. 2015 Mar 9;5:8919. doi: 10.1038/srep08919.

26.

β1 and β4 integrins: from breast development to clinical practice.

Nisticò P, Di Modugno F, Spada S, Bissell MJ.

Breast Cancer Res. 2014;16(5):459. Review.

27.

Asymmetric expression of connexins between luminal epithelial- and myoepithelial- cells is essential for contractile function of the mammary gland.

Mroue R, Inman J, Mott J, Budunova I, Bissell MJ.

Dev Biol. 2015 Mar 1;399(1):15-26. doi: 10.1016/j.ydbio.2014.11.026. Epub 2014 Dec 11.

28.

SnapShot: Branching Morphogenesis.

Chuong CM, Bhat R, Widelitz RB, Bissell MJ.

Cell. 2014 Aug 28;158(5):1212-1212.e1. doi: 10.1016/j.cell.2014.08.019.

29.

An interferon signature identified by RNA-sequencing of mammary tissues varies across the estrous cycle and is predictive of metastasis-free survival.

Snijders AM, Langley S, Mao JH, Bhatnagar S, Bjornstad KA, Rosen CJ, Lo A, Huang Y, Blakely EA, Karpen GH, Bissell MJ, Wyrobek AJ.

Oncotarget. 2014 Jun 30;5(12):4011-25.

30.

Cellular heterogeneity profiling by hyaluronan probes reveals an invasive but slow-growing breast tumor subset.

Veiseh M, Kwon DH, Borowsky AD, Tolg C, Leong HS, Lewis JD, Turley EA, Bissell MJ.

Proc Natl Acad Sci U S A. 2014 Apr 29;111(17):E1731-9. doi: 10.1073/pnas.1402383111. Epub 2014 Apr 14.

31.

Of plasticity and specificity: dialectics of the microenvironment and macroenvironment and the organ phenotype.

Bhat R, Bissell MJ.

Wiley Interdiscip Rev Dev Biol. 2014 Mar-Apr;3(2):147-63. doi: 10.1002/wdev.130. Epub 2013 Nov 18. Review.

PMID:
24719287
32.

Of plasticity and specificity: dialectics of the micro- and macro-environment and the organ phenotype.

Bhat R, Bissell MJ.

Wiley Interdiscip Rev Membr Transp Signal. 2014;3(2):147-163.

33.

Sorting out the FACS: a devil in the details.

Hines WC, Su Y, Kuhn I, Polyak K, Bissell MJ.

Cell Rep. 2014 Mar 13;6(5):779-81. doi: 10.1016/j.celrep.2014.02.021. No abstract available.

34.

CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8+ T cells.

Strachan DC, Ruffell B, Oei Y, Bissell MJ, Coussens LM, Pryer N, Daniel D.

Oncoimmunology. 2013 Dec 1;2(12):e26968. Epub 2013 Dec 4.

35.

The need for complex 3D culture models to unravel novel pathways and identify accurate biomarkers in breast cancer.

Weigelt B, Ghajar CM, Bissell MJ.

Adv Drug Deliv Rev. 2014 Apr;69-70:42-51. doi: 10.1016/j.addr.2014.01.001. Epub 2014 Jan 9. Review.

36.

Increased sugar uptake promotes oncogenesis via EPAC/RAP1 and O-GlcNAc pathways.

Onodera Y, Nam JM, Bissell MJ.

J Clin Invest. 2014 Jan;124(1):367-84. doi: 10.1172/JCI63146. Epub 2013 Dec 9.

37.

NFkB disrupts tissue polarity in 3D by preventing integration of microenvironmental signals.

Becker-Weimann S, Xiong G, Furuta S, Han J, Kuhn I, Akavia UD, Pe'er D, Bissell MJ, Xu R.

Oncotarget. 2013 Nov;4(11):2010-20.

38.

Toward plasmonics-enabled spatiotemporal activity patterns in three-dimensional culture models.

Lee SE, Alivisatos AP, Bissell MJ.

Syst Biomed (Austin). 2013 Jan;1(1). doi: 10.4161/sysb.22834.

39.

14-3-3σ stabilizes a complex of soluble actin and intermediate filament to enable breast tumor invasion.

Boudreau A, Tanner K, Wang D, Geyer FC, Reis-Filho JS, Bissell MJ.

Proc Natl Acad Sci U S A. 2013 Oct 8;110(41):E3937-44. doi: 10.1073/pnas.1315022110. Epub 2013 Sep 25.

40.

Epimorphin is a novel regulator of the progesterone receptor isoform-a.

Bascom JL, Radisky DC, Koh E, Fata JE, Lo A, Mori H, Roosta N, Hirai Y, Bissell MJ.

Cancer Res. 2013 Sep 15;73(18):5719-29. doi: 10.1158/0008-5472.CAN-13-0021. Epub 2013 Jul 18.

41.

The perivascular niche regulates breast tumour dormancy.

Ghajar CM, Peinado H, Mori H, Matei IR, Evason KJ, Brazier H, Almeida D, Koller A, Hajjar KA, Stainier DY, Chen EI, Lyden D, Bissell MJ.

Nat Cell Biol. 2013 Jul;15(7):807-17. doi: 10.1038/ncb2767. Epub 2013 Jun 2.

42.

The hemopexin domain of MMP3 is responsible for mammary epithelial invasion and morphogenesis through extracellular interaction with HSP90β.

Correia AL, Mori H, Chen EI, Schmitt FC, Bissell MJ.

Genes Dev. 2013 Apr 1;27(7):805-17. doi: 10.1101/gad.211383.112.

43.

Patterned collagen fibers orient branching mammary epithelium through distinct signaling modules.

Brownfield DG, Venugopalan G, Lo A, Mori H, Tanner K, Fletcher DA, Bissell MJ.

Curr Biol. 2013 Apr 22;23(8):703-9. doi: 10.1016/j.cub.2013.03.032. Epub 2013 Apr 4.

44.

ATM suppresses SATB1-induced malignant progression in breast epithelial cells.

Ordinario E, Han HJ, Furuta S, Heiser LM, Jakkula LR, Rodier F, Spellman PT, Campisi J, Gray JW, Bissell MJ, Kohwi Y, Kohwi-Shigematsu T.

PLoS One. 2012;7(12):e51786. doi: 10.1371/journal.pone.0051786. Epub 2012 Dec 10.

45.

Transmembrane/cytoplasmic, rather than catalytic, domains of Mmp14 signal to MAPK activation and mammary branching morphogenesis via binding to integrin β1.

Mori H, Lo AT, Inman JL, Alcaraz J, Ghajar CM, Mott JD, Nelson CM, Chen CS, Zhang H, Bascom JL, Seiki M, Bissell MJ.

Development. 2013 Jan 15;140(2):343-52. doi: 10.1242/dev.084236.

46.

Splicing program of human MENA produces a previously undescribed isoform associated with invasive, mesenchymal-like breast tumors.

Di Modugno F, Iapicca P, Boudreau A, Mottolese M, Terrenato I, Perracchio L, Carstens RP, Santoni A, Bissell MJ, Nisticò P.

Proc Natl Acad Sci U S A. 2012 Nov 20;109(47):19280-5. doi: 10.1073/pnas.1214394109. Epub 2012 Nov 5.

47.

Three-dimensional cultures of mouse mammary epithelial cells.

Mroue R, Bissell MJ.

Methods Mol Biol. 2013;945:221-50. doi: 10.1007/978-1-62703-125-7_14.

48.

Three-dimensional culture of human breast epithelial cells: the how and the why.

Vidi PA, Bissell MJ, Lelièvre SA.

Methods Mol Biol. 2013;945:193-219. doi: 10.1007/978-1-62703-125-7_13.

49.

FAM83A confers EGFR-TKI resistance in breast cancer cells and in mice.

Lee SY, Meier R, Furuta S, Lenburg ME, Kenny PA, Xu R, Bissell MJ.

J Clin Invest. 2012 Sep;122(9):3211-20. doi: 10.1172/JCI60498. Epub 2012 Aug 13.

50.

An "elite hacker": breast tumors exploit the normal microenvironment program to instruct their progression and biological diversity.

Boudreau A, van't Veer LJ, Bissell MJ.

Cell Adh Migr. 2012 May-Jun;6(3):236-48. doi: 10.4161/cam.20880. Epub 2012 May 1. Review.

Supplemental Content

Loading ...
Support Center